IONS — Ionis Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Ionis Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	C2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-Q	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,500	1,892	2,115	1,987	2,331
Net Total Accounts Receivable
Net Total Receivables	63	76.2	61.9	25.5	97.8
Total Inventory
Total Other Current Assets
Total Current Assets	2,721	2,131	2,345	2,203	2,642
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	166	181	196	256	243
Net Intangible Assets
Other Long Term Assets
Total Assets	3,233	2,390	2,612	2,534	2,990
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	273	599	241	312	448
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	1,762	1,646	1,840	1,961	2,603
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,471	743	772	573	387
Total Liabilities & Shareholders' Equity	3,233	2,390	2,612	2,534	2,990
Total Common Shares Outstanding